This research investigates how New Zealand's childhood vision screening programme can better detect and treat vision problems. By trialling more frequent and accurate screening alongside fully funded school-based eye examinations, the project aims to improve eye-care access, reduce inequalities, inform national policy, and ensure every child has the opportunity to see clearly.

This research tests whether positive, therapy-induced epigenetic changes can be inherited. Using mice with genetic eye disease, the team applies a successful treatment, checks for vision improvement, examines resulting DNA chemical marks, and studies whether offspring inherit these beneficial modifications. Findings could reshape our understanding of therapy and generational health impact.